{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:13:04Z","timestamp":1761894784498},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.clineuro.2008.06.011","type":"journal-article","created":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T02:44:52Z","timestamp":1224038692000},"page":"905-912","source":"Crossref","is-referenced-by-count":48,"title":["Non-MS autoimmune demyelination"],"prefix":"10.1016","volume":"110","author":[{"given":"Nada","family":"Cikes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dubravka","family":"Bosnic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirna","family":"Sentic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2008.06.011_bib1","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jbspin.2006.05.006","article-title":"Neuropsychiatric manifestations of systemic lupus erythematosus","volume":"73","author":"Bruns","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.clineuro.2008.06.011_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/rheumatology\/41.6.605","article-title":"The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation","volume":"41","author":"Jennekens","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.clineuro.2008.06.011_bib3","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","article-title":"Clinical patterns of neurological involvement in Behcet's disease: evaluation of 200 patients","volume":"122","author":"Akmar-Demir","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2008.06.011_bib4","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1212\/WNL.31.11.1391","article-title":"Sjoegren's syndrome: central nervous system manifestations","volume":"31","author":"Alexander","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2008.06.011_bib5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1212\/WNL.43.2.455-a","article-title":"MS and Sjoegren's syndrome","volume":"43","author":"Alexander","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2008.06.011_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp.2005.075861","article-title":"Demyelination in rheumatic diseases","volume":"84","author":"Theodoridou","year":"2008","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.clineuro.2008.06.011_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clineuro.2005.11.009","article-title":"Central nervous system involvement in systemic connective tissue diseases","volume":"108","author":"Cikes","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.clineuro.2008.06.011_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/rheumatology\/41.6.619","article-title":"The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms in clinical syndromes: a literature investigation","volume":"41","author":"Jennekans","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.clineuro.2008.06.011_bib9","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clineuro.2008.06.011_bib10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/rheumatology\/keh581","article-title":"Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"44","author":"Jimenez","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clineuro.2008.06.011_bib11","unstructured":"ACR nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1992;42:599\u2013608."},{"key":"10.1016\/j.clineuro.2008.06.011_bib12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/rheumatology\/keh532","article-title":"Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?","volume":"44","author":"Ferreira","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.clineuro.2008.06.011_bib13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1196\/annals.1351.010","article-title":"Anti-Endothelial antibodies and neuropychiatric systemic lupus erythematosus","volume":"1069","author":"Valesini","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.clineuro.2008.06.011_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.semarthrit.2006.11.003","article-title":"Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome","volume":"36","author":"Zandman-Goddard","year":"2007","journal-title":"Semin Arthritis Rheum"},{"issue":"12 December","key":"10.1016\/j.clineuro.2008.06.011_bib15","doi-asserted-by":"crossref","first-page":"E498","DOI":"10.1371\/journal.pmed.0030498","article-title":"Antibodies and brain disease: a convergence of immunology and physiology","volume":"3","author":"Diamond","year":"2006","journal-title":"Plos Med"},{"key":"10.1016\/j.clineuro.2008.06.011_bib16","first-page":"2093","article-title":"The Pathogenesis of neuropsychiatric manifestations in systemic lupus erythematosus: a disease in search of autoantibodies, or autoantibodies in search of a disease?","volume":"31","author":"Senecal","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clineuro.2008.06.011_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/qjmed\/93.3.169","article-title":"Risk factors for central nervous system involvement in systemic lupus erythematosus","volume":"93","author":"Karassa","year":"2000","journal-title":"QJM"},{"key":"10.1016\/j.clineuro.2008.06.011_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.2005.041640","article-title":"Raised monocyte chemotactic protein-1 (MCP-1)\/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus","volume":"65","author":"Likuni","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clineuro.2008.06.011_bib19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jneuroim.2006.09.003","article-title":"Anti-triosephosphate isomerase antibodies in cerebrospinal fluid are associated with neuropsychiatric lupus","volume":"181","author":"Sasajima","year":"2006","journal-title":"J Neuroimmunol"},{"issue":"Suppl. 2","key":"10.1016\/j.clineuro.2008.06.011_bib20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/096120339800700201","article-title":"The antiphospholipid syndrome. A historical view","volume":"7","author":"Hughes","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.clineuro.2008.06.011_bib21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/jnnp.68.2.170","article-title":"Brain involvement in systemic immune mediated disease: magnetic resonance and magnetisation transfer imaging study","volume":"68","author":"Rovaris","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clineuro.2008.06.011_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/qjmed\/93.8.497","article-title":"Warfarin for multiple sclerosis?","volume":"93","author":"Ruiz-Irastoza","year":"2000","journal-title":"Q J Med"},{"key":"10.1016\/j.clineuro.2008.06.011_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s004150170135","article-title":"Neurological complications of primary Sjoegren's syndrome","volume":"248","author":"Lafitte","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.clineuro.2008.06.011_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1176\/jnp.11.2.241","article-title":"CNS Sjoegren's syndrome: an underrecognized and underappreciated neuropsychiatric disorder","volume":"11","author":"Cox","year":"1999","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.clineuro.2008.06.011_bib25","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/BOR.0b013e328277ef4c","article-title":"An important role for B Cell activation factor and B cells in the pathogenesis of Sjogren's syndrome","volume":"19","author":"Mackay","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clineuro.2008.06.011_bib26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/ard.62.2.168","article-title":"The level of BlyS(BAFF) correlates with the titre of autoantibodies in human Sjogren\u2019 syndrome","volume":"62","author":"Mariette","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clineuro.2008.06.011_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s004150050205","article-title":"Behcet\u2019 disease and the nervous system","volume":"245","author":"Serdaroglu","year":"1998","journal-title":"J Neurol"},{"key":"10.1016\/j.clineuro.2008.06.011_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s002340050356","article-title":"MRI in neuro-Behcet\u2019 disease","volume":"39","author":"Tali","year":"1997","journal-title":"Neuroradiology"},{"key":"10.1016\/j.clineuro.2008.06.011_bib29","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/ard.59.8.622","article-title":"Familial aggregation of Behcet's disease in Turkey","volume":"59","author":"Gul","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clineuro.2008.06.011_bib30","first-page":"515","article-title":"Thrombosis associated with the prothrombin G\u2013A20210 mutation in Behcet's disease","volume":"27","author":"Salvarani","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clineuro.2008.06.011_bib31","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.4049\/jimmunol.162.7.4328","article-title":"Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases","volume":"162","author":"Matsui","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.clineuro.2008.06.011_bib32","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00296-006-0282-5","article-title":"Multiple sclerosis associated with systemic sclerosis","volume":"27","author":"Pelidou","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clineuro.2008.06.011_bib33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/archneur.61.1.126","article-title":"Transverse myelitis in systemic sclerosis","volume":"61","author":"Torabi","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clineuro.2008.06.011_bib34","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11910-007-0072-9","article-title":"Progressive multifocal leukoencephalopathy","volume":"7","author":"Berger","year":"2007","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.clineuro.2008.06.011_bib35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2007.11.013","article-title":"The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases","volume":"30","author":"Boren","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clineuro.2008.06.011_bib36","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa054693","article-title":"Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy","volume":"354","author":"Yousry","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clineuro.2008.06.011_bib37","first-page":"236","article-title":"Neurological complications of Infliximab","volume":"34","author":"Roos","year":"2007","journal-title":"J Rheumatol"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846708002126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846708002126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T12:08:25Z","timestamp":1684584505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846708002126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0303846708002126"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2008.06.011","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}